GRHL2 upregulation predicts a poor prognosis and promotes the resistance of serous ovarian cancer to cisplatin
Y Nie, Y Ding, M Yang - OncoTargets and therapy, 2020 - Taylor & Francis
Background GRHL2 has been shown to function in ovarian carcinogenesis. However, the
relationship between GRHL2 and cisplatin (DDP) resistance in serous ovarian cancer (SOC) …
relationship between GRHL2 and cisplatin (DDP) resistance in serous ovarian cancer (SOC) …
KHDRBS3 promotes paclitaxel resistance and induces glycolysis through modulated MIR17HG/CLDN6 signaling in epithelial ovarian cancer
X Wu, L Qiu, H Feng, H Zhang, H Yu, Y Du, H Wu… - Life Sciences, 2022 - Elsevier
Paclitaxel (PTX) resistance contributes to mortality in epithelial ovarian cancer (EOC).
Aerobic glycolysis is elevated in the tumor environment and may influence resistance to PTX …
Aerobic glycolysis is elevated in the tumor environment and may influence resistance to PTX …
Exploration of the Correlation Between GRHL1 Expression and Tumor Microenvironment in Endometrial Cancer and Immunotherapy
S Guo, W Bai, F Cui, X Chen, X Fang… - Pharmacogenomics …, 2024 - Taylor & Francis
Introduction GRHL1 belongs to the family of Grainyhead-like (GRHL). Previous studies have
shown that dysregulation of growth and survival pathways is associated with the GRHL …
shown that dysregulation of growth and survival pathways is associated with the GRHL …
Inhibition of GRP78 expression reverses cisplatin resistance in human ovarian cancer
LM Fan, J Su, H Dong, M Wei, MH Cui - Zhonghua yi xue za zhi, 2013 - europepmc.org
Objective To explore the effects of GRP78 suppression on the sensitivity to cisplatin and
elucidate the role and mechanism of GRP78 in ovarian cancer cisplatin resistance. Methods …
elucidate the role and mechanism of GRP78 in ovarian cancer cisplatin resistance. Methods …
Dysregulation of lnc-SNHG1 and miR-216b-5p correlate with chemoresistance and indicate poor prognosis of serous epithelial ovarian cancer
ML Pei, ZX Zhao, T Shuang - Journal of Ovarian Research, 2020 - Springer
Aim This study aimed to explore whether the dysregulation of lnc-small nucleolar RNA host
gene 1 (SNHG1) and miR-216b-5p correlated with chemoresistance and indicated poor …
gene 1 (SNHG1) and miR-216b-5p correlated with chemoresistance and indicated poor …
[HTML][HTML] Experimental and clinical evidence suggests that GRPEL2 plays an oncogenic role in HCC development
MC Lai, QQ Zhu, J Xu, WJ Zhang - American journal of cancer …, 2021 - ncbi.nlm.nih.gov
Hepatocellular carcinoma (HCC) continues to cause severe burden worldwide. The limited
options especially toward HCC with metastasis prompts us to identify novel molecules for …
options especially toward HCC with metastasis prompts us to identify novel molecules for …
Suppression of the grainyhead transcription factor 2 gene (GRHL2) inhibits the proliferation, migration, invasion and mediates cell cycle arrest of ovarian cancer cells
A Faddaoui, R Sheta, M Bachvarova, M Plante… - Cell Cycle, 2017 - Taylor & Francis
Previously, we have identified the Grainyhead transcription factor 2 gene (GRHL2) as
notably hypomethylated in high-grade (HG) serous epithelial ovarian tumors, compared with …
notably hypomethylated in high-grade (HG) serous epithelial ovarian tumors, compared with …
Inhibition of HDAC1 and DNMT1 modulate RGS10 expression and decrease ovarian cancer chemoresistance
RGS10 is an important regulator of cell survival and chemoresistance in ovarian cancer. We
recently showed that RGS10 transcript expression is suppressed during acquired …
recently showed that RGS10 transcript expression is suppressed during acquired …
Knockdown of GRHL2 inhibited proliferation and induced apoptosis of colorectal cancer by suppressing the PI3K/Akt pathway
F Hu, Z He, C Sun, D Rong - Gene, 2019 - Elsevier
Abstract Grainyhead-like 2 (GRHL2) transcription factor is implicated in many types of
cancers. However, the role of GRHL2 in colorectal cancer (CRC) has not been fully …
cancers. However, the role of GRHL2 in colorectal cancer (CRC) has not been fully …
Co-overexpression of GRK5/ACTC1 correlates with the clinical parameters and poor prognosis of epithelial ovarian cancer
L Liu, J Lv, Z Lin, Y Ning, J Li, P Liu… - Frontiers in Molecular …, 2022 - frontiersin.org
Background: The prognosis of epithelial ovarian cancer (EOC) is poor, and the present
prognostic predictors of EOC are neither sensitive nor specific. Objective: The aim of this …
prognostic predictors of EOC are neither sensitive nor specific. Objective: The aim of this …